Scientists develop innovative non-opioid pain killer
Scientists from the University of Warwick have developed a non-opioid pain killer with minimal side effects.
Opioids are a class of drugs that work to...
WHO: Alarming data shows childhood vaccinations are declining
Official data from WHO and UNICEF finds the largest sustained decline in childhood vaccinations in around 30 years.
In the UK, children up to 15...
S100A9 protein may provide an alternative to insulin therapy
University of Geneva (UNIGE) scientists have demonstrated that the S100A9 protein can be developed into an effective diabetes treatment and could one day replace...
NICE recommends two new affordable breast cancer treatments
NICE has agreed to an affordable deal for two breast cancer treatments, available immediately to patients on the NHS.
In the final draft guidance, NICE...
NICE approves first new mesothelioma cancer treatment in 15 years
Exciting news arrives from the NHS as they announce the first treatment for mesothelioma cancer in over a decade is now approved.
This new treatment...
Extending the UK’s leadership with an antibiotic subscription model to tackle AMR
Following the UK’s top ranking in the recent AMR Preparedness Index, Michael Hodin and Peter Jackson discuss the country’s novel antibiotic subscription model and...
Alpelisib becomes 100th fast tracked NHS cancer drug
Alpelisib – a life-extending drug for patients with advanced breast cancer – has become the 100th fast-tracked cancer drug on the NHS and will...
Experimental drug repairs nerve damage from spinal cord injury
A groundbreaking study from the University of Birmingham has shown that a candidate drug called AZD1390 can repair nerve damage following a spinal cord...
Microdosing psilocybin shows effectiveness in improving mental health
Evidence from a University of British Colombia investigation suggests that microdosing psilocybin may be an effective treatment for mental health conditions.
The Microdose.me project, published in...
New universal influenza B vaccine offers extensive protection
A new universal influenza B vaccine offers a strong defence against different strains and improved immune protection.
A new study by biomedical scientists from the Institute...
Protein discovery may create new treatments for HIV
Scientists have uncovered the mechanism behind a crucial protein that causes HIV to spread. The findings may help to develop novel treatments for HIV.
Researchers...
Fat burning peptide may help to design an effective weight loss drug
Brazilian scientists have demonstrated that a new peptide has powerful anti-obesity properties in a rodent study and may help develop a potent weight loss...
Common ADHD medications may treat Alzheimer’s disease
An extensive data analysis has revealed that widely used ADHD medications may be effective at reducing the impact of Alzheimer’s disease.
The investigation examined the...
Broadening the availability of orphan drugs
Ahead of the EU’s revision of the regulatory framework governing orphan drugs, we spoke to the European Medicines Agency about some of the key...
Lamivudine HIV drug improves Down syndrome cognitive impairment
An antiretroviral drug that is traditionally used to treat HIV – known as lamivudine – has been shown to improve cognitive abilities in a...
Scientists create a vaccine basis for a common pollen allergy
New research could mean scientists are getting closer to a vaccine for mugwort, a common pollen allergy.
A research team at MedUni Vienna has discovered...
New targeted treatment for early-stage breast cancer available on NHS
Provisional approval by NICE could see a step-change in treatment for early-stage breast cancer following surgery.
The National Institute of Health and Care Excellence (NICE)...
NHS treats first sickle cell disease patients with new drug
One of the first sickle cell disease patients has received a life-changing drug called crizanlizumab, the first new treatment for the disease in over...
NICE recommend new treatment to support kidney transplant
A new treatment recommended by NICE increases the chance of a successful kidney transplant and could revolutionise future surgeries.
In the new final draft guidance,...
The cost of brand-name epilepsy drugs has risen by 277%
New research finds that the costs of brand-name epilepsy drugs have rapidly increased by 277% from 2010 to 2018.
Epilepsy is a common condition affecting...
